Open-label Evaluation of the Population Pharmacokinetic Profile, Safety, Tolerability, and Efficacy of Tapentadol Oral Solution for the Treatment of Post-surgical Pain in Children Aged From Birth to Less Than 2 Years
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2017
At a glance
- Drugs Tapentadol (Primary)
- Indications Acute pain
- Focus Pharmacokinetics
- Sponsors Grunenthal
- 12 Jan 2017 Status changed from recruiting to discontinued.
- 08 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
- 08 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016.